We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
An outbreak of meningococcal meningitis has been reported in Niger. In the first two months of 2016, a total of 414 cases and 33 related deaths were recorded. During the same time period of 2015, just 95 cases were recorded. Cases have been reported in the following districts: Niamey, Tahoua, Tillabery and Dosso (South West of Niger).
Meningococcal serogroup C is thought to be responsible for the outbreak but this has yet to be confirmed. An immunisation campaign is already underway in affected areas with 72 878 individuals vaccinated. The target population for immunisation is 546 045.
(Via European Commission ECHO Daily Flash - accessed 08/03/16)
Vaccination against meningococcal meningitis is sometimes recommended for travellers to Niger.
Vaccination is dependant on an individual risk assessment but should be considered for travel to a region with a current outbreak/ongoing epidemic where close, prolonged contact with the local population is anticipated, particularly in overcrowded areas and during the high risk season.
